26 related articles for article (PubMed ID: 10807145)
1. Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.
Grobbee EJ; Wisse PHA; Schreuders EH; van Roon A; van Dam L; Zauber AG; Lansdorp-Vogelaar I; Bramer W; Berhane S; Deeks JJ; Steyerberg EW; van Leerdam ME; Spaander MC; Kuipers EJ
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD009276. PubMed ID: 35665911
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of the immunochemical fecal occult blood test for colorectal cancer screening in Brazil.
Teixeira CR; Bonotto ML; Lima JP; Figueiredo LF; Conrado L; Frasca C
Ann Gastroenterol; 2017; 30(4):442-445. PubMed ID: 28655982
[TBL] [Abstract][Full Text] [Related]
3. Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design.
Juul JS; Bro F; Hornung N; Andersen BS; Laurberg S; Olesen F; Vedsted P
BMC Cancer; 2016 Jul; 16():445. PubMed ID: 27400657
[TBL] [Abstract][Full Text] [Related]
4. Screening for colorectal cancer with FOBT, virtual colonoscopy and optical colonoscopy: study protocol for a randomized controlled trial in the Florence district (SAVE study).
Sali L; Grazzini G; Carozzi F; Castiglione G; Falchini M; Mallardi B; Mantellini P; Ventura L; Regge D; Zappa M; Mascalchi M; Milani S
Trials; 2013 Mar; 14():74. PubMed ID: 23497601
[TBL] [Abstract][Full Text] [Related]
5. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels.
Hol L; Wilschut JA; van Ballegooijen M; van Vuuren AJ; van der Valk H; Reijerink JC; van der Togt AC; Kuipers EJ; Habbema JD; van Leerdam ME
Br J Cancer; 2009 Apr; 100(7):1103-10. PubMed ID: 19337257
[TBL] [Abstract][Full Text] [Related]
6. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?
Grazzini G; Visioli CB; Zorzi M; Ciatto S; Banovich F; Bonanomi AG; Bortoli A; Castiglione G; Cazzola L; Confortini M; Mantellini P; Rubeca T; Zappa M
Br J Cancer; 2009 Jan; 100(2):259-65. PubMed ID: 19142185
[TBL] [Abstract][Full Text] [Related]
7. Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme.
Ciatto S; Martinelli F; Castiglione G; Mantellini P; Rubeca T; Grazzini G; Bonanomi AG; Confortini M; Zappa M
Br J Cancer; 2007 Jan; 96(2):218-21. PubMed ID: 17211476
[TBL] [Abstract][Full Text] [Related]
8. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
9. Colorectal carcinoma: is screening possible?
Bonelli L
Tech Coloproctol; 2004 Dec; 8 Suppl 2():s267-72. PubMed ID: 15666104
[TBL] [Abstract][Full Text] [Related]
10. Screening for colorectal cancer by faecal occult blood test: comparison of immunochemical tests.
Castiglione G; Zappa M; Grazzini G; Rubeca T; Turco P; Sani C; Ciatto S
J Med Screen; 2000; 7(1):35-7. PubMed ID: 10807145
[TBL] [Abstract][Full Text] [Related]
11. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood.
Castiglione G; Grazzini G; Miccinesi G; Rubeca T; Sani C; Turco P; Zappa M
J Med Screen; 2002; 9(3):99-103. PubMed ID: 12370319
[TBL] [Abstract][Full Text] [Related]
12. Cost analysis in a population based screening programme for colorectal cancer: comparison of immunochemical and guaiac faecal occult blood testing.
Castiglione G; Zappa M; Grazzini G; Sani C; Mazzotta A; Mantellini P; Ciatto S
J Med Screen; 1997; 4(3):142-6. PubMed ID: 9368871
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme.
Castiglione G; Visioli CB; Ciatto S; Grazzini G; Bonanomi AG; Rubeca T; Mantellini P; Zappa M
Br J Cancer; 2007 Jun; 96(11):1750-4. PubMed ID: 17453007
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of RPHA fecal occult blood test in screening for colorectal cancer].
Yu H
Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):108-10. PubMed ID: 2401172
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
